Hydrumedical is a pioneering medical device enterprise that was established in 2016 with a clear emphasis on innovating new urological medical devices. Their primary offering, Hydrustent, is a biodegradable ureteral stent that has been patented for its pioneering technological foundation. The company specializes in the development of urological devices, particularly ureteral stents, and it extends technical and consultation services throughout every stage of medical product development.
Hydrumedical operates within the Health Care and Medical Devices industries and is headquartered in Portugal. As of now, there is no information available regarding the last investment or the investors involved. Nonetheless, with its focus on innovation in urological devices and its patent for a biodegradable ureteral stent, Hydrumedical is positioned as a promising and potentially impactful player in the medical device industry.There is no investment information
No recent news or press coverage available for Hydrumedical.